Clinda sola es suficiente en HS

Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations

Raffaele Dante Caposiena Caro, MD^a,∗,

Email the author MD Raffaele Dante Caposiena Caro

, 

Maria Vittoria Cannizzaro, MD^a

, 

Elisabetta Botti, MD^a

, 

Cosimo Di Raimondo, MD^a

, 

Eleonora Di Matteo, MD^a

, 

Roberta Gaziano, MD^b

, 

Luca Bianchi, MD^a

Published Online: November 28, 2018

PlumX Metrics

https://doi.org/10.1016/j.jaad.2018.11.035

Article Infoclick to expand contents 

Background

Antibiotics are recognized as first-line treatments for hidradenitis suppurativa (HS), but the data on their efficacy are limited.

Objective

Evaluate the efficacy of oral clindamycin versus that of clindamycin plus rifampicin in patients with HS.

Methods

A total of 60 patients with mild-to-moderate-severe HS who were classified according to their International Hidradenitis Suppurativa Severity Score System (IHS4) and Hurley scores, were subdivided into 2 groups of 30 patients each (group A, the members of which received clindamycin plus rifampicin, and group B, the members of which were treated with clindamycin alone) and retrospectively studied. The main objective was to evaluate and compare the clinical and ultrasound responses between the groups after 8 weeks of treatment according to the Hidradenitis Suppurativa Clinical Response measure.

Results

After the treatment, 17 of 30 patients in group A and 19 of 30 in group B met the primary outcome. Both groups showed a similar improvement of IHS4 score, whereas the Dermatology Life Quality Index and pain Visual Analogue Scale scores improved more in group B. In particular, the reductions in nodule and abscess counts were similar between the 2 groups, whereas the number of draining tunnels decreased more in group B. The factors significantly associated with Hidradenitis Suppurativa Clinical Response score were age, body mass index, IHS4 score, and absence of axillary involvement. Disease-free survival was similar between the 2 groups.

Limitations

The study was not randomized or placebo-controlled.

Conclusion

Clindamycin may be a useful treatment alternative to antibiotic combination regardless of HS clinical stage.

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.